fig3
Figure 3. Disease free survival (DFS). The DFS at time of operation according to A, circulating microRNA-126 (cir-miRNA-126), B circulating epidermal growth factor-like domain 7 (cir-EGFL7), and C the combined estimate
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Navigation
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Follow OAE
